featured
Spironolactone Use Does Not Increase the Risk of Female Breast Cancer Recurrence
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Spironolactone Use Does Not Increase the Risk of Female Breast Cancer Recurrence: A Retrospective Analysis
J Am Acad Dermatol 2020 May 21;[EPub Ahead of Print], C Wei, P Bovonratwet, A Gu, G Moawad, PK Sculco, JI Silverberg, AJ FriedmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.